BOSTON, MA - (February 27, 2024) - As the United States Drug Supply Chain Security Act (U.S. DSCSA) approaches its full regulatory enforcement deadline on November 27, 2024, there has been a significant increase in preparation activities among TraceLink customers and their trading partners. Key statistics highlighting the industry’s progress on TraceLink include:
- Over 1,300 TraceLink customers and partners are already exchanging DSCSA Electronic Product Code Information Services (EPCIS) messages, well ahead of the November deadline.
- More than 1.7 million DSCSA EPCIS transactions have been exchanged by TraceLink customers in the past 12 months.
- Over 1 million of these EPCIS transactions occurred in the last 90 days alone, indicating rapid acceleration and maturation in readiness efforts.
- 26,070 companies have already been successfully enabled for DSCSA compliance on TraceLink, and they have created over 47,000 links to exchange EPCIS information. Read more >
TraceLink’s network platform, with Integrate Once, Interoperate with Everyone™ capability, revolutionizes compliance and operational efficiency for dispensing customers. By seamlessly connecting with an expansive digital network of supply chain partners, TraceLink ensures robust compliance with the Drug Supply Chain Security Act (DSCSA), swiftly manages compliance exceptions, and enables streamlined digital recalls. Furthermore, its advanced analytics capabilities facilitate the prediction of drug shortages, enhancing supply chain resilience. This integration offers pharmacies, hospitals, and other dispensers a comprehensive solution that not only meets regulatory demands but also optimizes inventory management and maintains the integrity of the drug supply, ensuring patient safety and continuity of care.
